ACHP Statement on CY2026 MA and Part D Rate Notice
ACHP commends the Trump Administration for finalizing policies in the …
04/07/2025
Now the preferred choice for America’s seniors, Medicare Advantage offers a coordinated, benefit-rich option with better health outcomes at an affordable price. ACHP and its member health companies believe that protecting and enhancing Medicare Advantage is in the best interests of all seniors and gives taxpayers the best value for their investment.
MA: The Choice of America's Seniors
DOWNLOADACHP commends the Trump Administration for finalizing policies in the …
04/07/2025
ACHP President and CEO Ceci Connolly released a statement in …
04/04/2025
ACHP is grateful for its longstanding partnership with CMS and …
04/03/2025
ACHP represents the nation’s top-performing nonprofit health companies, which serve …
03/24/2025
ACHP sent a letter to Russel Vought, the Director of …
02/20/2025
ACHP, HealthScape Advisors and The Chartis Group discuss MA trends …
04/04/2024
ACHP's Michael Bagel presents MA for Tomorrow as an opportunity …
03/18/2024
January 5, 2023 by Michael Bagel In a recent op-ed for MedCity …
01/06/2023
By offering lower costs, more benefits and better outcomes, …
02/26/2024
ACHP's Michael Bagel explains why it's time to raise standards …
11/01/2022
ACHP calls on Congress to curb direct-to-consumer (DTC) drug ad dominance. Patients should be able to access affordable, necessary medications, rather than being swayed by misleading marketing tactics.
04/10/2025
ACHP sent a letter to Dr. Mehmet Oz with commonsense reforms that cut unnecessary red tape and save precious health care dollars.
04/10/2025
ACHP comments on the CMS Marketplace Integrity and Affordability Proposed Rule.
04/10/2025
ACHP commends the Trump Administration for finalizing policies in the 2026 MA and Part D Rate Notice that reflect higher care delivery costs and for taking another step toward reining …
04/07/2025